Myopia treatment trends outlined in The Vision Council's recent report

In examining regulatory approvals and product availability across the US, Canada, the UK, and the EU, 4 treatment categories were developed in the form of low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology. Image credit: AdobeStock/Myst

New research from The Vision Council was published in part of a 2-part report that combined a global analysis of pediatric myopia treatment strategies with a survey of US eye care providers.¹ The report, Focused inSights 2025: Myopia Management, reported that the majority of providers value proactive screening and adopting myopia management into their practice to combat myopia, according to a news release.

“This dual-format report provides both a global and a local lens on myopia management,” said Alysse Henkel, vice president of Research and inSights at The Vision Council, in the release. “It’s clear from the survey that US eyecare providers take myopia seriously, but they also face challenges in making care affordable and ensuring families understand the importance of treatment. By also including an international analysis of treatment options and regulatory environments, this report offers a comprehensive view of where childhood myopia care stands today, and where it is headed.”

The report also unveiled how treatment options may differ across regions, how regulatory environments shape access, and how US clinicians are approaching diagnosis, management, and patient education. Additionally, a total of 293 optometrists, practice owners, and managers were involved in the survey from June 16 to July 4, 2026 in order to assess how myopia management is implemented in US practices.¹

In examining regulatory approvals and product availability across the US, Canada, the UK, and the EU, 4 treatment categories were developed in the form of low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology.¹ “The study highlights uneven adoption across markets, recent milestones such as the EU’s approval of Ryjunea atropine drops, and France’s move to fully reimburse myopia control spectacle lenses,” the release stated.

As for the US providers, 91% reported that they recommend myopia screenings at least once a year, with approximately 70% stating that they offer myopia management for children in their practice. In the US, MiSight contact lenses were the most frequently prescribed for myopia management at 81%, with motivations for treatment being slowing the progression of myopia (78%), reducing complication risks (78%), and improving long-term eye health (71%).¹

Additionally, risk factors identifying by eye care providers include excessive screen time (82%), genetics (82%), and limited outdoor activity (77%). Challenges in treatment were cost (86%), parental understanding (56%), and patient compliance (49%).¹

Reference:

1. The Vision Council releases new report on myopia treatment trends. News release. The Vision Council. September 9, 2025. Accessed September 11, 2025. https://thevisioncouncil.org/blog/vision-council-releases-new-report-myopia-treatment-trends